Micro-energy treatments include low-intensity extracorporeal shockwave therapy, low-intensity pulsed ultrasound, and electromagnetic fields.

The FDA has approved Gazyva (obinutuzumab) for the treatment of adult patients with active lupus nephritis who are receiving standard therapy.

In the absence of head-to-head randomized trials, investigators performed a network meta-analysis to compared drugs for post-transplant diabetes.

(HealthDay News) — Many people with cancer get directly involved in prior authorization (PA), often facing substantial time burdens, according to a study presented at the 2025 American Society of ...

(HealthDay News) — Overdose deaths in older adults from fentanyl mixed with stimulants, such as cocaine and methamphetamine, have surged in the past eight years, according to a study presented at the ...

Higher prevalence was seen for antiviral-treated patients compared with untreated counterparts. (HealthDay News) — Patients with chronic hepatitis B (CHB) have an increased prevalence of chronic ...

Association between continued smoking and all-cause mortality also seen in patients with advanced-stage cancer.

Cosmo Fowler, M.D., from Emory University in Atlanta, and colleagues examined data from the TriNetX U.S. Collaborative Network to examine whether OSA modifies outcomes in patients with T2DM receiving ...

A trial emulation assessed whether GLP-1RA use improves cardiovascular, kidney, and death outcomes in patients with systemic lupus erythematosus, including lupus nephritis.

Benefit with sotatercept seen among adults with pulmonary arterial hypertension diagnosed less than a year earlier.

(HealthDay News) — Phthalate exposure is associated with adverse effects on cardiovascular health in patients with chronic kidney disease (CKD), according to a study published online in Renal Failure.

High proportion of time in deep sedation linked to loss of independent living among patients who lived independently before ICU admission.